arrow
J

Ji-Won Kim

seoul national university
H指数:29
被引数:3,282

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vactosertib plus pembrolizumab in patients with non-microsatellite instability-high metastatic colorectal or gastric cancer: a multicenter, phase Ib/IIa study

Vactosertib联合pembrolizumab治疗非微卫星不稳定性高转移性结直肠癌或胃癌患者的多中心、 Ib/IIa期研究

2026-07-210
OA
Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial

仑伐替尼联合帕博利珠单抗对比标准护理方案在复发性/转移性头颈鳞状细胞癌中的疗效:随机、II期LEAP-009试验

2026-05-220
PRE
Survival Rates of Patients with Gastric Cancer According to Age and Sex: A Large-Scale Study Using Data from 14,739 Patients

胃癌患者的生存率按年龄和性别划分:一项基于14,739例患者数据的大规模研究

2026-01-014
OAAI
Pilot Study for Feasibility of Onco-Geriatric Intervention Model in Older Patients with Cancer in a Tertiary Academic Hospital

在三级教学医院中针对老年癌症患者开展肿瘤-老年干预模型的可行性初步研究

2026-01-010
OA
Early growth response 1 as a key regulator of PD-L1 expression and immune evasion in extranodal NK/T-cell lymphoma

早期生长反应1作为PD-L1表达和免疫逃逸的关键调节因子在结外NK/T细胞淋巴瘤中的作用

2025-06-130
OAAI
High-Throughput Chemotherapeutic Drug Screening System for Gastric Cancer (Cure-GA)

胃癌高通量化疗药物筛选系统 (cure-ga)

2025-01-230
OAAI
Clinical implementation of next-generation sequencing testing and genomically-matched therapy: a real-world data in a tertiary hospital
2025-01-160
OAAI
Association of TP53 Mutation Status and Sex with Clinical Outcome in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Cohort Study

TP53突变状态与性别对接受免疫检查点抑制剂治疗的非小细胞肺癌患者临床结局的影响:一项回顾性队列研究

2025-01-151
OA
Sex-dependent different clinicopathological characterization of Epstein-Barr virus-associated gastric carcinoma: a large-scale study

Epstein-barr病毒相关胃癌的性别依赖性不同临床病理特征: 一项大规模研究

2024-01-110
OAAI